Immunity to Mxuberculosis (MTB) infection consists of interactions between various T-cell subsets that control the infection and prevent further reactivation. We analysed the effector/memory T-cell dynamics and cytokines production in the peripheral blood of patients with pulmonary tuberculosis (TB). We observed that the frequency of CD4+ T-cell effectors was significantly increased during active TB, confirming a major role of this T-cell subset in TB immunity. Pre-terminally differentiated CD8+ Tlymphocytes were increased in the peripheral blood as well. In contrast, we observed a reduced number of effector mycobacteria-reactive "{o+ T-Iymphocytes with a specific defects in reacting to mycobacterial nonpeptidic antigens, suggesting that this innate response is rapidly lost during TB infection. Nevertheless, thefrequency of"{o+ T -cells effectors in TB patients was higher than the a [3+ T-cell response to peptide from MTB-ESAT-6 protein and quantitatively similar to PPD reactivity. Thus, a[3+and "{o+ T-cell differentiation and function are differently triggered by active TB infection.
Tuberculosis (TB) is a global health problem: one third of the world's population is infected with Mycobacterium tuberculosis (MTB). Anti-MTB immunity consists of a complex series of interactions between various cell populations that must control and constrain the infection as well as prevent it from further reactivation. Both CD4+ and CD8+ T-cells have a role in fighting MTB infection (1). Mycobacteria-specific CD4+T-cells are important for providing protective immunity through a potent IFN-'Y production (2) . Despite its residence within phagosomes, MTB is capable of stimulating MHC class I-restricted CD8+ T-cells although the underlying mechanism remains to be established (3) . Finally, a second class of MTB nonpeptidic antigens is composed of phosphometabolites that activate 'Y8+T-cells without the need for antigen processing and presentation (4) . Altogether, effector T-cells, including conventional CD4+ and CD8+ T-cells and . unconventional T-cells such as 'Y8+ T-cells and CD l-glycolipid-specific a.f3+ T-cells, can produce IFN-'Y that is a central factor in the activation of anti-mycobacterial activities of macrophages, and hence considered crucial for protection against TB (4) .
. Routine immunosurveillance involves constant recirculation oflymphocytes through tissues. CCR7 is a chemokine receptor that is expressed on naive T-lyrnphocytes and is lost after antigen-specific activation in Iymphonodes acquiring a memory phenotype (5) . Likewise, the interaction between C027 and its ligand C070 induces costimulatory signals in naive T-cells and C027 expression is lost on memory T-cells, as a result of persistent antigenic stimulation (6) . In this study we analysed the effector/memory T-cell dynamics based on the expression ofCCR7, C027 and C045RA markers and their functional reactivity in TB patients. In addition cytokine production by af3+ and ')'0+ Tcells was evaluated by stimulation with mycobacterial antigens such as PPO, ESAT-6 and IPP.
MATERIAL AND METHODS

Patients
Peripheral blood samples were obtained from 20 patients (mean age: 38.8± 19.8) 14males and 6 females, with primary diagnosis of pulmonary TB reeruited at the National Institute for Infectious Diseases "Lazzaro Spallanzani" (Rome, Italy). Sixteen HIV'TB' donors (HD) were used as normal controls. In TB patients, clinical presentation and chest radiographs were compatible with pulmonary TB. Sputum was positive for acid-fast bacilli stain and culture. All TB patients were HIV-negative with no evidence of other concurrent diseases. Informed consent was obtained from patients and healthy donors. All clinical research experiments were done in accordance with a protocol approved by the Lazzaro Spallanzani Institute's Ethical Committee.
Blood culture and detection of cytokine-secreting cells
PBMC were separated by density gradient centrifugation (Ficoll-Hypaquc, Pharmacia Biotech, Norway). Enzyme-linked immunospot (ELISpot) assay and intracellular cytokine staining (ICS) were used for enumeration and characterisation 0 I'antigen-speci fie T cells. For ICS, I x I0 6 cclls/rnl in complete medium' (RPMI 1640, 10% v/v heat-inactivated FCS, 2 mM L-Glutamine, 10 U/ml penicillin/streptomycin), were incubated in the presence of 120 mM isopcntenylpyrophosphate (IPP; Sigma Chemical Co., ST. Louis, MO) and 100 U/ml rIL-2 (Boehringer Mannhcim Corp., Mannheim, Germany) or with mytogens (PMA at 50 ng/ml plus ionornycin at 10 mg/ml), at 37°C and 5% CO 2 for I hr followed by an additional 5 hr incubation with 10 mg/rnl of the secretion inhibitor Brefeldin-A (Sigma). ICS was performed as previously described (7) and analysed on a FACScal ibur (Becton Dickinson). Control for non-specific staining was always included with isotypc-rnatchcd mAbs and subtracted from specific results. For ELISpot assay for identification of individual IFN--y secreting cells, 2x I 0 5 PBMC were plated in duplicates in complete medium, in 96 well plates (MAIPS45; Millipore, Sunnyvale, CA) prccoated with IFN--y capture antibody (M-700A, Endogen, Woburn, MA), and incubated for 48 hrs at 37°C and 5% CO 2 , M. tuberculosis Early Secretory Antigen (ESAT)-6 (6-28) multiepitopic and promiscuous peptide (WNFAGIEAAASAIQGNVTSIHSL) (50 mg/mL), PPD (10 mg/mL) (batch RT47; Statens Serum Institut, Copenhagen, Denmark) and IPP were used as antigens. Spots were counted by an automated ELISA-Spot assay video analysis system (AELVIS, Hannover, Germany). The total number of antigen-speci fie T cells was calculated after subtracting the mean ofthe background number of Spot Forming Colonies (SFCs) in the negative control from the mean of the spots number in the sample.
Monoclonal antibodies (I1IAbs)
Anti-Vo2 mAbs, (IgG I, clone IMMU I 464), were obtained from Immunotech, Marseille, France. Anti-CD4 (IgGI, clone RPA-T4), anti-CD8 (IgGI, clone RPA-T8), anti-CD27 (IgGI, clone M-T271), anti-CD45RA (IgG 2h , clone HI! 00), Anti-IFN--y (IgG I, clone B27), anti-TNF-a (IgG I, clone Mab II) m Abs, purified anti-CCR7 (IgM, clone 2H4) and biotin-conjugated rat anti-mouse IgM (IgG2a, clone R6-60.2) mAbs were purchased from Becton Dickinson Biosciences, San Jose, CA. Fluorochrome-conjugated control mAbs (IgG I clone MOPC-21, Becton Dickinson) were used in all experiments.
Statistical evaluation
Differences among group means were evaluated by Mann-Whitney test. Values ofp<0,05 were considered significant.
RESULTS
Dynamics of effector/memory T-cell subsets in the peripheral blood of TB patients
We analysed the expression of three surface differentiation markers of effector and long-term/ memory on C04+, C08+ and ')'0+T-cells in PBMC of patients with pulmonary TB according to the expression ofC045RA, CCR7 and C027 molecules. staining of CD4+T-cells with CD45RA and CD27 mAbs permits clear discrimination of the three main CD4+T-cell subsets: CD45RA+/CD27+ naive cells; CD45RA-/CD27+ long-term/memory-cells; and CD45RA-/CD27-effector/memory-cells. In comparison, an increase in effector/memory CD4+ T-cell subsets frequency was observed in TB patients (Fig. 1, panels A and C) . Similarly, the percentage of CD45RA-/CD27-or CD45RA-/CCR7-CD4+ Tcell effectors was increased and was statistically different in TB patients vs HD (Fig.1, panels B and D; CD45RA-/CD27-/CD4+ T-cell effectors: 21.1 ±3.88% vs 10.5 ±1.8%, p=0.02; CD45RA-/ CCR7-/CD4+ T-cell effectors: 28.04 ±5.3% vs 13.35 ±2,45%, p=0.03). The expression of CD45RA and CD27 molecules on CD8+T-cells permits discrimination of four the same subsets as reported for CD4+ Tcells with a further subpopulation CD45RA+/CD27of terininally differentiated effector-cells.
Comparing TB patients to HD (Fig. I , panel E and G), an increase in the frequency of CD45RA-/ CD27-/CD8+ T-cell precursors of effector CTL was observed in TB patients. This subset was increased and was statistically different in TB patients vs HD (25.1±4.5% vs 13.3±2.8%, p=0.04).
In parallel, a reduction in naive CD45RA+/CD27+/ CD8+ T-cells was observed. The frequency of naive CD8+ T-cells, was significantly reduced in TB patients 25.0±3.8% in TB+ vs 42.3±6.3% in HD; p=0.02). Similarly, the expression ofCD45RA and CCR7 molecules on CD8+ T-cells permits this subset does not recirculate extensively in lymph nodes.
. Analysis ofcytokine-production by effectors T-cell subsets in response to stimulation with TB antigens. The functional analysis ofT-cells subsets was analysed in HD and TB patients. In panel A, the cytokine production was determined at singlecell level by intracellular staining with specific mAbs after 6 hr ofIPP stimulation in the presence ofbrefeldin A. 1'0+ T-cell subsets were discriminated by surface staining. TNF-a and IFN-1' production was analysed in 10 HD (open bars) and 15 TB patient (hatched bars). Inpanel B, IFN-1' production was evaluated in PBMe by
Analysis of cytokine-production by effector T-cell subsets in response to stimulation with TB antigens
We have evaluated the frequency of cytokine production among af3+ and 1'0+ T-cells in TB patients and in HD. Fig. 2 shows the percentage of TNF-a and IFN-I' production by 1'0+ T-cells. As shown in panel A, 1'0+ T-cells produce significant amounts ofTh I cytokines confirming the specificity of this reactivity. However, we observed a reduced capacity of IPP-stimulated 1'0+ T-cells to secrete pro inflammatory cytokines in patients with active-TB vs HD (l2.2±9.6% vs 32.4±4.0% of TNF-a production; p<O.05; 8.6±6.8% vs 32.4±4.0% of IFN-I' production, p<O.05). Mitogenic stimulation with lonomycin and PMA induced a broad lymphocytes activation and a strong cytokines production in 1'0+ T-cells restoring 1'0+ T-cells function in TB patients. This suggests that the lower reactivity to IPP stimulation was an antigen specific functional defect (data not shown)
Using ELI Spot, we confirmed a reduced frequency ofIFN-v-producing effector-cells after stimulation with IPP in TB patients when compared However, no significant differences were observed comparing TB patients to HD, suggesting that the ability of CD8+ T-cells to recirculate through the lymphnodes is unchanged during active TB. The staining of 1'0+ T-cells with CD45RA and CD27 mAbs permits discrimination of two main 1'0+ T-cell subsets: CD45RA/CD27+ long-term/ memory-cells; and CD45RA/CD27-effector/ memory-cells. Comparing TB patients to HD, a decreased frequency of effector/memory 1'0+ Tcell subsets during TB disease was observed. Moreover, CD45RA/CD27-1'0+ T-cell effectors were reduced in TB patients (11.5±2.4% in TB+, 24.l±4.2% inHD; p=O.03). Similarly, the expression of CD45RA -and CCR7 1'0+ T-cells discriminates two main 1'0+ T-cell subsets. However, both in HD and in TB patients the majority of 1'0+ T-cells did not express the CCR7 molecule, suggesting that to HD (277.8±36 vs 1002.5±338 SFCs/million of IFN-')'; p=0.0023) ( fig. 2, panel B) . Recent studies have led to the identification of a genomic segment, RDl, specifically present in MTB (8) . RD1 gene products, and in particular Early secretory antigenic target (ESAT)-6, evoke a specific response in TB patients. Accordingly, we observed a significant IFN-')' production in TB patients with respect to HD, when compared with IFN-')' production after PPD stimulation. PPD is a crude precipitate of MTB containing antigens widely shared among environmental mycobacteria and thus is poorly specific. Nevertheless, the residual reactivity to IPP in TB patients was higher than TB-specific ESAT-6 responses of a[3+ T-cells (277.8±36 vs 81.4±9.5 SFCs/million of IFN-')') and similar to unspecific PPD reactivity also observed in HD (277.8±36 SFCs/million of IFN-')' in PBMC from TB patients in vitro stimulated with IPP, 370.7±46.5 and 280±37.5 respectively in PBMC from TB+ and HD in vitro stimulated with ESAT-6peptide).
DISCUSSION
The intracellular location of M.tuberculosis hides it from antibody recognition. Thus, T-cells must be activated to overcome the antibacterial defence mechanism. However, the contribution of specific T-cell subsets is still unclear. Several studies demonstrated that CD4+ T-cells play a central role in the protective immune response against MTB (9) . The primary effector function of CD4+T-cells is to release high levels ofIFN-')' and other cytokines activating macrophages which can control and eliminate intracellular pathogens. Although IFN-')' production was a central event in CD4 mediated immunity, several observations indicated other possible pathway for controlling TB infection (10) . IFN-')'-independent CD4dependent mechanisms for control of tuberculosis were also described. Recently, F. Sallusto et al. (5) reported that CCR7' effector T-cells have lost the capability forautocrine proliferation and ability to display specialised function such as IFN-')'/ TNF-a production. In our study, we analysed CCR7 surface expression on CD4+ T-cells and showed a significant increase in CD45RA-/CCR7' T-cells in TB patients vs HD, discriminating among different effector or long-term/memory T-cell subpopulations. Similarly, we observed that CD4+ T-cells of peripheral blood from TB patients accumulated within the CD45RA-/CD27' T-cell population.
Interest is emerging on the role of CD8+ Tcells in the immune response to M.tuberculosis. CD8+ T-cells, similarly to CD4+ T-cells, can produce IFN-')' , but their main function is target cell killing (II). Comparing TB patients to HD we observed an increase of the frequency ofCD45RA-/CD27' CD8+ T-cell precursors of effector CTL during TB. In parallel, we observed a reduction of naive CD8+ T-cell in TB patients. However, there were no significant difference in the surface expression ofCCR7 between TB patients and HD, suggesting that the ability of CD8+ T-cells to recirculate through the lymph nodes is unchanged during TB.
Human ')'0+ T-lymphocytes are source of cytokines (12) (13) (14) and are activated by MTB, although their role in the protective immune response to MTB is not as well defined (7) . Human ')'0+ Tcells are stimulated in vitro by a unique group of nonpeptidic Ags containing phosphate which are abundant in mycobacteria (15) . Specifically, this ')'0+ T-cell subset readily produces IFN-')' after stimulation with phospholigands and expresses granule-dependent mycobacteriocidal activity (16) . Staining ')'0+ T-cells with CD45RA and CD27 mAbs, permits discrimination of two main ')'0+ Tcell subsets: CD45RA-/CD27+ long-term/memory cells, and CD45RA-/CD27' effector/memory cells. The pool of CD45RA-/CD27'i')'0+ T-cells was reduced during active TB. Moreover, we found a lack ofIFN-')' producing ')'o+T-cells upon stimulation with nonpeptidic mycobacterial ligands. Accordingly, several reports have shown thatMTBstimulated PBMC produce reduced amounts of IFN-')' in both adult TB patients and children with primary TB disease, when compared to healthy tuberculin reactors (17) (18) . These observations of disease-specific changes in ')'8+ T-cell function demonstrate a correlation between ')'8+ T-cell effector functions and manifestations of disease, consistent with the hypothesis that these T-cells may playa role in the immune response to MTB infection.
In conclusion, M.tuberculosis infection differently influences the activation and differentiation patterns of CD4+, CD8+ and ')'8+ Tcell subsets. Although effector CD4+ T-cells are the dominant and critical T-cell subset in protection against MTB, "(o+ T-cells appear to have an important complementary role which is partially lost during active TB disease. Thus, phenotypic and functional analysis of T-cell subsets may have a diagnostic value for monitoring TB infection.
